ReviewAnnals of African medicine2026
Ethical, Social, and Legal Issues Related to Precision Medicine in India: Challenges and Solutions.
Review in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractPrecision medicine customizes healthcare based on individual genetics, environment, and lifestyle, offering a transformative approach to treatment. It promises improved health outcomes through precise and effective interventions. However, its implementation in India presents significant ethical, social, and legal challenges. Ethical concerns include ensuring informed consent, safeguarding patient privacy, and preventing genetic discrimination, particularly in a population with varied literacy levels and health awareness. Social barriers include high costs, rural inaccessibility, and cultural resistance to genetic testing. Legally, gaps in genetic testing regulation, unclear data ownership, and expensive patented treatments pose hurdles. Overcoming these challenges requires a comprehensive strategy, including healthcare-specific data protection policies, financial subsidies for low-income groups, and stringent regulatory frameworks. Such steps can ethically integrate precision medicine into the Indian healthcare system, balancing individual rights with its vast potential benefits and fostering equitable access to this innovative medical approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.